ReproTOX is a biotechnology company specialized in developing in vitro alternative approaches to predict reproductive toxicity. It promotes technologies developed by ReproTOX in the field of the reproductive biology and toxicology and more specially in in vitro male reproductive Toxicology. ReproTOX supports the discovery efforts of its partners by providing tools, solutions and services for the male in vitro reproductive toxicological studies.

The ReproTOX team is a group of highly skilled scientists with a proven performance-driven attitude and provides their expertise in our comprehensive discovery platforms, which includes expertise in:

  • Male Reproductive cell line isolation & 3D in vitro cultures
  • Biochemical and cellular assay development
  • High Throughput (HT) and High Content Analysis (HCA)
  • Computational machine learning based HCA analysis

News

Aug 2017

WC10 (the 10th Congress on Alternatives and Animal Use in the Life Sciences) took take place at the Washington State Convention Center in Seattle on August 20-24, 2017. Dr. Yu co-chaired the Session of Models of Developmental and Reproductive Biology and presented "An animal-free in vitro three-dimensional testicular cells co-culture model for evaluating male reproductive toxicants".

July 2017

New publication in ToxSci " An Animal-Free In Vitro Three-Dimensional Testicular Cell Coculture Model for Evaluating Male Reproductive Toxicants"

January 2017

New publication in ToxSci " High-Content Analysis Provides Mechanistic Insights into the Testicular Toxicity"

August 2016

ReproTOX receive federal SBIR award to pursue 3D testicular cells model for reproductive toxicity testing: 3D-T®Repro.

July 2016

ReproTOX is partnering with National Toxicology Program (NTP) for high-throughput screening for reproductive toxicity.